{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:00:21Z","timestamp":1793833221451,"version":"4.6.1"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer New York","isbn-type":[{"value":"9781493989966","type":"print"},{"value":"9781493989973","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8997-3_20","type":"book-chapter","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T04:56:34Z","timestamp":1549515394000},"page":"349-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Animal Models of Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"Sam W. Z.","family":"Olechnowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BGM, Rajkumar SV et al (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121\u20131127","journal-title":"Leukemia"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-13-2645","volume":"74","author":"SWZ Olechnowicz","year":"2014","unstructured":"Olechnowicz SWZ, Edwards CM (2014) Contributions of the host microenvironment to cancer-induced bone disease. Cancer Res 74:1625\u20131631","journal-title":"Cancer Res"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","volume":"20","author":"IR Garrett","year":"1997","unstructured":"Garrett IR, Dallas S, Radl J, Mundy GR (1997) A murine model of human myeloma bone disease. Bone 20:515\u2013520","journal-title":"Bone"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/bjc.1992.415","volume":"66","author":"LS Manning","year":"1992","unstructured":"Manning LS, Berger JD, O\u2019Donoghue HL et al (1992) A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL\/KaLwRij mouse. Br J Cancer 66:1088\u20131093","journal-title":"Br J Cancer"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/bjc.1997.409","volume":"76","author":"K Vanderkerken","year":"1997","unstructured":"Vanderkerken K, De Raeve H, Goes E et al (1997) Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL\/KaLwRij mouse. Br J Cancer 76:451\u2013460","journal-title":"Br J Cancer"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/leu.2014.295","volume":"29","author":"ST Lwin","year":"2015","unstructured":"Lwin ST, Olechnowicz SWZ, Fowler JA, Edwards CM (2015) Diet-induced obesity promotes a myeloma-like condition in vivo. Leukemia 29:507\u2013510","journal-title":"Leukemia"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-11-2067","volume":"72","author":"JA Fowler","year":"2012","unstructured":"Fowler JA, Mundy GR, Lwin ST, Edwards CM (2012) Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1. Cancer Res 72:2183\u20132189","journal-title":"Cancer Res"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"e0127828","DOI":"10.1371\/journal.pone.0127828","volume":"10","author":"SR Amend","year":"2015","unstructured":"Amend SR, Wilson WC, Chu L et al (2015) Whole genome sequence of multiple myeloma-prone C57BL\/KaLwRij mouse strain suggests the origin of disease involves multiple cell types. PLoS One 10:e0127828","journal-title":"PLoS One"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neo.2014.07.002","volume":"16","author":"JE Noll","year":"2014","unstructured":"Noll JE, Hewett DR, Williams SA et al (2014) SAMSN1 is a tumor suppressor gene in multiple myeloma. Neoplasia 16:572\u2013585","journal-title":"Neoplasia"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1242\/dmm.003160","volume":"2","author":"J a Fowler","year":"2009","unstructured":"Fowler J a, Mundy GR, Lwin ST et al (2009) A murine model of myeloma that allows genetic manipulation of the host microenvironment. Dis Model Mech 2:604\u2013611","journal-title":"Dis Model Mech"},{"issue":"7","key":"20_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/blood-2004-01-0236","volume":"104","author":"Y. Mori","year":"2004","unstructured":"Mori Y, Shimizu N, Dallas M et al (2004) Anti-\u03b14 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. Blood 104","journal-title":"Blood"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"e0119546","DOI":"10.1371\/journal.pone.0119546","volume":"10","author":"MA Lawson","year":"2015","unstructured":"Lawson MA, Paton-Hough JM, Evans HR et al (2015) NOD\/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease. PLoS One 10:e0119546","journal-title":"PLoS One"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1359\/jbmr.1999.14.2.256","volume":"14","author":"H Hjorth-Hansen","year":"1999","unstructured":"Hjorth-Hansen H, Seifert MF, B\u00f6rset M et al (1999) Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. J Bone Miner Res 14:256\u2013263","journal-title":"J Bone Miner Res"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1158\/1078-0432.CCR-10-0173","volume":"16","author":"C Cocco","year":"2010","unstructured":"Cocco C, Giuliani N, Di Carlo E et al (2010) Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin Cancer Res 16:4188\u20134197","journal-title":"Clin Cancer Res"},{"key":"20_CR15","first-page":"6689","volume":"63","author":"CS Mitsiades","year":"2003","unstructured":"Mitsiades CS, Mitsiades NS, Bronson RT et al (2003) Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID\/NOD in vivo model: biologic and clinical implications. Cancer Res 63:6689\u20136696","journal-title":"Cancer Res"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.bbmt.2012.04.004","volume":"18","author":"E Bartee","year":"2012","unstructured":"Bartee E, Chan WM, Moreb JS et al (2012) Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus. Biol Blood Marrow Transplant 18:1540\u20131551","journal-title":"Biol Blood Marrow Transplant"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00262-006-0196-9","volume":"56","author":"K-D Wu","year":"2006","unstructured":"Wu K-D, Zhou L, Burtrum D et al (2006) Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis. Cancer Immunol Immunother 56:343\u2013357","journal-title":"Cancer Immunol Immunother"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbrc.2003.11.120","volume":"313","author":"Y Miyakawa","year":"2004","unstructured":"Miyakawa Y, Ohnishi Y, Tomisawa M et al (2004) Establishment of a new model of human multiple myeloma using NOD\/SCID\/gammac(null) (NOG) mice. Biochem Biophys Res Commun 313:258\u2013262","journal-title":"Biochem Biophys Res Commun"},{"key":"20_CR19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V95.3.1056.003k26_1056_1065","volume":"95","author":"LM Pilarski","year":"2000","unstructured":"Pilarski LM, Hipperson G, Seeberger K et al (2000) Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood 95:1056\u20131065","journal-title":"Blood"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/nm.4202","volume":"22","author":"R Das","year":"2016","unstructured":"Das R, Strowig T, Verma R et al (2016) Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. Nat Med 22:1351\u20131357","journal-title":"Nat Med"},{"key":"20_CR21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V90.2.754","volume":"90","author":"M Urashima","year":"1997","unstructured":"Urashima M, Chen BP, Chen S et al (1997) The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 90:754\u2013765","journal-title":"Blood"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/sj.leu.2403513","volume":"18","author":"K Yata","year":"2004","unstructured":"Yata K, Yaccoby S (2004) The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 18:1891\u20131897","journal-title":"Leukemia"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/leu.2010.300","volume":"25","author":"T Calimeri","year":"2011","unstructured":"Calimeri T, Battista E, Conforti F et al (2011) A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia 25:707\u2013711","journal-title":"Leukemia"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/bonekey.2015.142","volume":"5","author":"ST Lwin","year":"2016","unstructured":"Lwin ST, Edwards CM, Silbermann R (2016) Preclinical animal models of multiple myeloma. Bonekey Rep 5:772","journal-title":"Bonekey Rep"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bone.2015.04.004","volume":"77","author":"J Paton-Hough","year":"2015","unstructured":"Paton-Hough J, Chantry AD, Lawson MA (2015) A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease. Bone 77:57\u201368","journal-title":"Bone"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1158\/1535-7163.MCT-07-0121","volume":"6","author":"BO Oyajobi","year":"2007","unstructured":"Oyajobi BO, Mu\u00f1oz S, Kakonen R et al (2007) Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging. Mol Cancer Ther 6:1701\u20131708","journal-title":"Mol Cancer Ther"}],"container-title":["Methods in Molecular Biology","Bone Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8997-3_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T03:40:17Z","timestamp":1573875617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8997-3_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493989966","9781493989973"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8997-3_20","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"8 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}